(Q48326739)

10 February 2018

title

Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas (English)

1 reference

10 February 2018

1 reference

H B Newton

1

1 reference

10 February 2018

J Bromberg

2

1 reference

10 February 2018

L Junck

3

1 reference

10 February 2018

M A Page

4

1 reference

10 February 2018

H S Greenberg

5

1 reference

10 February 2018

publication date

1 March 1993

1 reference

10 February 2018

Journal of Neuro-Oncology

published in

1 reference

10 February 2018

volume

15

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

257-263

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/bf01050072

exact match

0 references

cites work

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

12 December 2020

Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma

1 reference

12 December 2020

O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea

1 reference

12 December 2020

Principles of brain tumor chemotherapy

1 reference

12 December 2020

O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts

1 reference

12 December 2020

Chemotherapy for malignant gliomas

1 reference

12 December 2020

Interstitial chemotherapy for brain tumors: review

1 reference

12 December 2020

Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma

1 reference

12 December 2020

Cytotoxicity and DNA damage caused by the azoxy metabolites of procarbazine in L1210 tumor cells

1 reference

12 December 2020

Cross-linking of DNA induced by chloroethyinitrosourea is prevented by O6-methyiguanine-DNA methyttransferase

1 reference

12 December 2020

Hematopoietic colony-stimulating factors

1 reference

12 December 2020

Increased repair of O6-alkylguanine DNA adducts in glioma-derived human cells resistant to the cytotoxic and cytogenetic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea.

1 reference

12 December 2020

Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors

1 reference

12 December 2020

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

12 December 2020

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

12 December 2020

Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure

1 reference

12 December 2020

The in vivo cytotoxic activity of procarbazine and procarbazine metabolites against L1210 ascites leukemia cells in CDF1 mice and the effects of pretreatment with procarbazine, phenobarbital, diphenylhydantoin, and methylprednisolone upon in vivo pr

1 reference

12 December 2020

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01050072

1 reference

10 February 2018

1 reference

10 February 2018